Latest News about REGN
Recent news which mentions REGN
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
From Benzinga
Will Regeneron Be Worth More Than Amazon by 2030?
October 28, 2021
From Motley Fool
1 Small-Cap Stock With 10X Potential
October 27, 2021
From Motley Fool
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
From Motley Fool
From Benzinga
Biotech Buyouts That Would Be Great for Investors
October 22, 2021
From Motley Fool
Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
October 22, 2021
From Motley Fool
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
From Benzinga
From Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
From Benzinga
2 Best Biotech Stocks to Buy Right Now
October 18, 2021
From Motley Fool
3 No-Brainer Biotech Stocks to Buy Right Now
October 16, 2021
From Motley Fool
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
From Motley Fool
2 Cheap Growth Stocks That Could Be Even Better Buys in November
October 15, 2021
From Motley Fool
90,000 U.S. adult deaths from COVID-19 over the summer could have been prevented if victims had been vaccinated, study finds
October 14, 2021
From MarketWatch
Pfizer Just Scored Another Key Regulatory Approval
October 14, 2021
From Motley Fool
3 Biotech Stocks You Can Buy and Hold for the Next Decade
October 13, 2021
From Motley Fool
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
From Benzinga
Why Humana Is Suing Biogen
October 09, 2021
From Motley Fool
Regeneron Could Have a Big Catalyst Coming in 2022
October 09, 2021
From Motley Fool
Cramer Likes DraftKings, Skyworks, And These Automakers
October 07, 2021
From Benzinga
Is This The Turning Point for Inovio?
October 06, 2021
From Motley Fool
Tesla and Merck Give Investors Some Hope
October 04, 2021
From Benzinga
3 Stocks That Might Soar With Pills for COVID
October 03, 2021
From Motley Fool
Here Are the Leaders in the Race to Develop a COVID-19 Pill
October 03, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.